Staci L. Sudenga, Ph.D. - Publications

Affiliations: 
2013 Epidemiology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Epidemiology

41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Mukherjee A, Ye Y, Wiener HW, Kuniholm MH, Minkoff H, Michel K, Palefsky J, D'Souza G, Rahangdale L, Butler KR, Kempf MC, Sudenga SL, Aouizerat BE, Ojesina AI, Shrestha S. Variations in Genes Encoding Human Papillomavirus Binding Receptors and Susceptibility to Cervical Pre-Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 37410084 DOI: 10.1158/1055-9965.EPI-23-0300  0.649
2023 Ye Y, Maroney KJ, Wiener HW, Mamaeva OA, Junkins AD, Burkholder GA, Sudenga SL, Khushman M, Al Diffalha S, Bansal A, Shrestha S. RNA-seq analysis identifies transcriptomic profiles associated with anal cancer recurrence among people living with HIV. Annals of Medicine. 55: 2199366. PMID 37177979 DOI: 10.1080/07853890.2023.2199366  0.475
2022 Umutoni V, Schabath MB, Nyitray AG, Wilkin TJ, Villa LL, Lazcano-Ponce E, Giuliano AR, Sudenga SL. The Association Between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35653709 DOI: 10.1158/1055-9965.EPI-21-1373  0.482
2021 Shing JZ, Griffin MR, Chang RS, Beeghly-Fadiel A, Sudenga SL, Slaughter JC, Pemmaraju M, Mitchel EF, Hull PC. Human Papillomavirus Vaccine Impact on Cervical Precancers in a Low-Vaccination Population. American Journal of Preventive Medicine. PMID 34756753 DOI: 10.1016/j.amepre.2021.08.017  0.372
2021 Shing JZ, Beeghly-Fadiel A, Griffin MR, Chang RS, Sudenga SL, Slaughter JC, Pemmaraju M, Mitchel EF, Hull PC. The Impact of the Human Papillomavirus Vaccine on High-Grade Cervical Lesions in Urban and Rural Areas: An Age-Period-Cohort Analysis. Cancers. 13. PMID 34439369 DOI: 10.3390/cancers13164215  0.45
2021 Sudenga SL, Lotspeich SC, Nyitray AG, Sirak B, Shepherd BE, Messina J, Sereday KA, Silva RC, Abrahamsen M, Baggio ML, Quiterio M, Lazcano-Ponce E, Villa L, Giuliano AR. The role of external genital lesions in HIV seroconversion among men participating in a multinational study. Sexually Transmitted Diseases. PMID 34282740 DOI: 10.1097/OLQ.0000000000001516  0.533
2021 Jongen VW, Schim van der Loeff MF, Botha MH, Sudenga SL, Abrahamsen ME, Giuliano AR. Incidence and risk factors of C. trachomatis and N. gonorrhoeae among young women from the Western Cape, South Africa: The EVRI study. Plos One. 16: e0250871. PMID 33939747 DOI: 10.1371/journal.pone.0250871  0.356
2021 Ye Y, Burkholder GA, Mukherjee A, Chu D, Bansal A, Sudenga SL, Junkins A, Al Diffalha S, Saag MS, Shrestha S. A 12-year retrospective evaluation of anal pre-cancerous lesions and cancer in people living with HIV-1 infection in the Southeastern U.S. Infectious Agents and Cancer. 16: 14. PMID 33596943 DOI: 10.1186/s13027-021-00354-7  0.518
2018 Posso H, León-Maldonado L, Allen-Leigh B, Salmerón J, Quiterio M, Giuliano AR, Sudenga SL, Nyitray AG, Torres BN, Abrahamsen M, Lazcano-Ponce E. Prevalence and incidence of anal human papillomavirus infection in Mexican men: Need for universal prevention policies. Salud Publica De Mexico. 60: 645-652. PMID 30699269 DOI: 10.21149/8454  0.629
2018 Lazcano-Ponce E, Sudenga SL, Torres BN, Stoler M, León-Maldonado L, Allen-Leigh B, Posso H, Quiterio M, Hernández-Nevarez MDP, Salmerón J, Giuliano AR. Incidence of external genital lesions related to human papillomavirus among Mexican men. A cohort study. Salud Publica De Mexico. 60: 633-644. PMID 30699268 DOI: 10.21149/8461  0.577
2018 Mainali B, Schabath MB, Sudenga SL, Ye C, Wiener HW, Villa LL, Giuliano AR, Shrestha S. Variants in Immune-related Genes and Genital HPV 16 Persistence in Men. Papillomavirus Research (Amsterdam, Netherlands). PMID 30092369 DOI: 10.1016/J.Pvr.2018.08.001  0.753
2018 Pamnani SJ, Sudenga SL, Rollison DE, Ingles DJ, Abrahamsen M, Villa LL, Lazcano-Ponce E, Huang Y, Borenstein A, Giuliano AR. Recurrence of Genital Infections with Nine HPV Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) among Men in the HPV Infection in Men (HIM) Study. The Journal of Infectious Diseases. PMID 29800222 DOI: 10.1093/Infdis/Jiy300  0.683
2017 Nunes EM, López RVM, Sudenga SL, Gheit T, Tommasino M, Baggio ML, Ferreira S, Galan L, Silva RC, Lazcano-Ponce E, Giuliano AR, Villa LL, Sichero L. Concordance of Beta-papillomavirus across anogenital and oral anatomic sites of men: The HIM Study. Virology. 510: 55-59. PMID 28708973 DOI: 10.1016/J.Virol.2017.07.006  0.631
2017 Menezes LJ, Pokharel U, Sudenga SL, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, Schim van der Loeff MF, van der Laan LE, Kipping S, Taylor D, Giuliano AR. Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial. Sexually Transmitted Infections. PMID 28490581 DOI: 10.1136/Sextrans-2016-053046  0.668
2017 Sudenga SL, Torres BN, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, Schim Van der Loeff MF, Van der Laan LE, Kipping S, Taylor D, Giuliano AR. HPV SEROSTATUS PRE- AND POST-VACCINATION IN A RANDOMIZED PHASE II PREPAREDNESS TRIAL AMONG YOUNG WESTERN CAPE, SOUTH AFRICAN WOMEN: THE EVRI TRIAL. Papillomavirus Research (Amsterdam, Netherlands). 3: 50-56. PMID 28480334 DOI: 10.1016/J.Pvr.2017.02.001  0.631
2017 Sudenga SL, Torres BN, Silva R, Villa LL, Lazcano-Ponce E, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR. Comparison of the natural history of genital HPV infection among men by country: Brazil, Mexico, and the United States. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28446543 DOI: 10.1158/1055-9965.Epi-17-0040  0.676
2017 Silva RJ, Sudenga SL, Sichero L, Baggio ML, Galan L, Cintra R, Torres BN, Stoler M, Giuliano AR, Villa LL. HPV-related external genital lesions among men residing in Brazil. The Brazilian Journal of Infectious Diseases : An Official Publication of the Brazilian Society of Infectious Diseases. PMID 28399426 DOI: 10.1016/J.Bjid.2017.03.004  0.698
2017 Sudenga SL, Nyitray AG, Torres BN, Silva R, Villa L, Lazcano-Ponce E, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR. Comparison of anal HPV natural history among men by country of residence: Brazil, Mexico, and the United States. The Journal of Infection. PMID 28363585 DOI: 10.1016/J.Jinf.2017.03.010  0.628
2016 Rahman S, Pierce Campbell CM, Waterboer T, Rollison DE, Ingles DJ, Torres BN, Michel A, Sudenga SL, Pawlita M, Villa LL, Lazcano Ponce E, Borenstein AR, Wang W, Giuliano AR. Seroprevalence of cutaneous human papillomaviruses (HPV) among men in the multinational HIM Study. The Journal of General Virology. PMID 27902363 DOI: 10.1099/Jgv.0.000620  0.694
2016 Sudenga SL, Nelson Torres B, Fulp WJ, Silva R, Villa LL, Lazcano-Ponce E, Ingles DJ, Stoler M, Messina JL, Abrahamsen M, Baggio ML, Salmeron J, Quiterio M, Giuliano AR. Country-Specific HPV-related Genital Disease Among Men Residing in Brazil, Mexico, and the United States: The HIM Study. International Journal of Cancer. PMID 27681815 DOI: 10.1002/Ijc.30452  0.644
2016 Pamnani SJ, Sudenga SL, Viscidi R, Rollison DE, Torres BN, Ingles DJ, Abrahamsen M, Villa LL, Lazcano-Ponce E, Salmeron J, Quiterio M, Huang Y, Borenstein A, Giuliano AR. Impact of serum antibodies to HPV serotypes 6, 11, 16, 18 to risks of subsequent genital HPV infections in men: the HIM Study. Cancer Research. PMID 27535333 DOI: 10.1158/0008-5472.Can-16-0224  0.693
2016 Nunes EM, Sudenga SL, Gheit T, Tommasino M, Baggio ML, Ferreira S, Galan L, Silva RC, Pierce Campbell CM, Lazcano-Ponce E, Giuliano AR, Villa LL, Sichero L. Diversity of beta-papillomavirus at anogenital and oral anatomic sites of men: The HIM Study. Virology. 495: 33-41. PMID 27161202 DOI: 10.1016/J.Virol.2016.04.031  0.621
2015 Ingles DJ, Lin HY, Fulp WJ, Sudenga SL, Lu B, Schabath MB, Papenfuss MR, Abrahamsen ME, Salmeron J, Villa LL, Ponce EL, Giuliano AR. An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study. Papillomavirus Research (Amsterdam, Netherlands). 1: 126-135. PMID 27547836 DOI: 10.1016/J.Pvr.2015.09.001  0.673
2015 Giuliano AR, Viscidi R, Torres BN, Ingles DJ, Sudenga SL, Villa LL, Baggio ML, Abrahamsen M, Quiterio M, Salmeron J, Lazcano-Ponce E. Seroconversion Following Anal and Genital HPV Infection in Men: The HIM Study. Papillomavirus Research. 1: 109-115. PMID 26688833 DOI: 10.1016/J.Pvr.2015.06.007  0.706
2015 Sudenga SL, Torres BN, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, Engelbrecht S, Schim Van der Loeff MF, Van der Laan LE, Kipping S, Taylor D, Giuliano AR. Cervical HPV natural history among young Western Cape, South African women: The randomized control EVRI Trial. The Journal of Infection. PMID 26476151 DOI: 10.1016/J.Jinf.2015.10.001  0.667
2015 Sudenga SL, Ingles DJ, Pierce Campbell CM, Lin HY, Fulp WJ, Messina JL, Stoler MH, Abrahamsen M, Villa LL, Lazcano-Ponce E, Giuliano AR. Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study. European Urology. PMID 26051441 DOI: 10.1016/J.Eururo.2015.05.032  0.604
2015 Giuliano AR, Botha MH, Zeier M, Abrahamsen ME, Glashoff RH, van der Laan LE, Papenfuss M, Engelbrecht S, Schim van der Loeff MF, Sudenga SL, Torres BN, Kipping S, Taylor D. High HIV, HPV, and STI prevalence among young Western Cape, South African women: EVRI HIV prevention preparedness trial. Journal of Acquired Immune Deficiency Syndromes (1999). 68: 227-35. PMID 25415290 DOI: 10.1097/Qai.0000000000000425  0.616
2015 Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, Monsonego J, Franceschi S. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. International Journal of Cancer. Journal International Du Cancer. 136: 2752-60. PMID 25043222 DOI: 10.1002/Ijc.29082  0.685
2015 Ingles DJ, Lin HY, Fulp WJ, Sudenga SL, Lu B, Schabath MB, Papenfuss MR, Abrahamsen ME, Salmeron J, Villa LL, Lazcano Ponce E, Giuliano AR. An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study Papillomavirus Research. 1: 126-135. DOI: 10.1016/j.pvr.2015.09.001  0.627
2014 Sudenga SL, Shrestha S, Macaluso M, Partridge EE, Johanning GL, Piyathilake CJ. Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection. Gynecologic Oncology. 135: 560-4. PMID 25281494 DOI: 10.1016/J.Ygyno.2014.09.015  0.733
2014 Stanley MA, Sudenga SL, Giuliano AR. Alternative dosage schedules with HPV virus-like particle vaccines. Expert Review of Vaccines. 13: 1027-38. PMID 25001893 DOI: 10.1586/14760584.2014.935767  0.42
2014 Sudenga SL, Wiener HW, King CC, Rompalo AM, Cu-Uvin S, Klein RS, Shah KV, Sobel JD, Jamieson DJ, Shrestha S. Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV epidemiology research study (HERS). Plos One. 9: e99109. PMID 24918582 DOI: 10.1371/Journal.Pone.0099109  0.759
2014 Sudenga SL, Wiener HW, King CC, Rompalo AM, Cu-Uvin S. Dense genotyping of immune-related loci identifies variants associated with clearance of HPV among HIV-positive women in the HIV Epidemiology Research Study (HERS) (PLoS ONE (2014) 9, 6 (e99109) DOI: 10.1371/journal.pone.0099109) Plos One. 9. DOI: 10.1371/Journal.Pone.0102728  0.549
2013 Sudenga SL, Wiener HW, Shendre A, Wilson CM, Tang J, Shrestha S. Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents. Human Immunology. 74: 1696-700. PMID 23973891 DOI: 10.1016/J.Humimm.2013.08.010  0.737
2013 Sudenga SL, Rositch AF, Otieno WA, Smith JS. Knowledge, attitudes, practices, and perceived risk of cervical cancer among Kenyan women: brief report. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 895-9. PMID 23694983 DOI: 10.1097/Igc.0B013E31828E425C  0.44
2013 Sudenga SL, Shrestha S. Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. 17: e216-20. PMID 23453716 DOI: 10.1016/J.Ijid.2012.12.027  0.752
2012 Sudenga SL, Kempf MC, McGwin G, Wilson CM, Hook EW, Shrestha S. Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents. Sexually Transmitted Diseases. 39: 300-5. PMID 22421698 DOI: 10.1097/Olq.0B013E318244A90F  0.571
2012 Kravchenko J, Akushevich I, Sudenga SL, Wilson CM, Levitan EB, Shrestha S. Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females. Plos One. 7: e30736. PMID 22292027 DOI: 10.1371/Journal.Pone.0030736  0.761
2011 Sudenga SL, Royse KE, Shrestha S. Role and uptake of human papillomavirus vaccine in adolescent health in the United States. Adolescent Health, Medicine and Therapeutics. 2011: 63-74. PMID 24155627 DOI: 10.2147/Ahmt.S15941  0.616
2010 Shrestha S, Sudenga SL, Smith JS, Bachmann LH, Wilson CM, Kempf MC. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents. Bmc Infectious Diseases. 10: 295. PMID 20946655 DOI: 10.1186/1471-2334-10-295  0.743
2010 Kravchenko J, Sudenga S, Akushevich I, Wilson CM, Shrestha S. The approach to individualized prediction of human papillomavirus (HPV) infection persistence/clearance in HIV-1-positive adolescent girls based on dynamics of CD4+ counts, viral load, and HAART Infectious Agents and Cancer. 5. DOI: 10.1186/1750-9378-5-S1-A76  0.691
Show low-probability matches.